GW0742
GW0742
GW0742 (/ɡiːˈdʌbljuːˈzɪroʊˈfɔːrtuːˈtuː/) is a Peroxisome proliferator-activated receptor (PPAR) agonist that is often used in scientific research. It is specifically a PPARδ/β agonist.
Etymology
The term GW0742 is a systematic name derived from the initials of the pharmaceutical company GlaxoSmithKline (GSK) that developed the compound, followed by a unique identifying number.
Pharmacology
GW0742 is a potent and highly selective PPARβ/δ agonist, with a Ki of 1 nM for human PPARδ, and about 2 orders of magnitude less potent for human PPARα and PPARγ. It is inactive against a host of other nuclear hormone receptors.
Medical Uses
GW0742 has been used in the laboratory setting to study various aspects of cardiovascular health, metabolic disorders, and inflammatory diseases. It is not currently approved for use in humans.
Related Terms
- Peroxisome proliferator-activated receptor
- Agonist
- GlaxoSmithKline
- Ki
- Nuclear hormone receptors
- Cardiovascular health
- Metabolic disorders
- Inflammatory diseases
External links
- Medical encyclopedia article on GW0742
- Wikipedia's article - GW0742
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski